MENU

Fox Chase Cancer Center News

June 2, 2018

First Comparison of Two Newer Prostate Cancer Therapies Finds Vastly Different Cost-Effectiveness Between Strategies

PHILADELPHIA (June 2, 2018) – In recent years the Food and Drug Administration has approved several new drugs for men with newly diagnosed metastatic prostate cancer. A new study compares the cost-effectiveness of intravenous docetaxel (DC) and daily pill abiraterone acetate plus prednisone (AAP) and analyzes progression free and overall survival for each.

Crystal S. Denlinger, MD
June 1, 2018

Fox Chase Cancer Center Celebrates Cancer Survivors and Stresses the Importance of Care After Cancer Treatment

PHILADELPHIA (June 1, 2018) – National Cancer Survivors Day is June 3rd. Fox Chase Cancer Center is celebrating the lives of cancer survivors across the country. According to the National Cancer Institute, the term “cancer survivor” refers to any person with a history of cancer, from the time of diagnosis through the remainder of their life.

Denise Connolly, PhD
May 30, 2018

Search for Vulnerabilities in Ovarian Tumors Leads to NEDD9, an Important Protein in Several Cancer Types

PHILADELPHIA (May 30, 2018) – Scientists seeking a path to better patient outcomes in ovarian cancer have discovered that a scaffolding protein known to promote breast cancer and melanoma metastasis, but aid in suppressing hematologic cancers, is associated with aggressive ovarian tumor growth. 

Erica Golemis, PhD
May 25, 2018

Cilia on Cells Adjacent to Tumors can Impact Signaling that Influences Cancer Growth and Response to Treatment

PHILADELPHIA (May 25, 2018) – A growing body of research shows that cilia, minuscule protuberances on the surface of some cells, play a pivotal role in determining whether cancer cells grow, spread, and respond to therapy.

2018 ASCO Annual Meeting
May 24, 2018

Fox Chase Cancer Center Presentations at the ASCO Annual Meeting

PHILADELPHIA (May 24, 2018) – As nearly 40,000 cancer researchers, physicians, and advocates gather in Chicago for the American Society of Clinical Oncology (ASCO) Annual Meeting, nearly 20 Fox Chase Cancer Center faculty and students will present their research on a range of topics. 

May 23, 2018

Mariusz Wasik Joins Fox Chase Cancer Center as Chair of Pathology

PHILADELPHIA (May 23, 2018) – Mariusz A. Wasik, MD, has been appointed Chair of the Department of Pathology at Fox Chase Cancer Center and Jeanes Hospital, joining the faculty on July 2.. He will also serve as Associate Director of the Cancer Center. 

May 21, 2018

Salvage Cryoablation Shows Clinical Benefit in Delaying Hormone Therapy for Men with Locally Recurrent Prostate Cancer

PHILADELPHIA (May 19, 2018) – Androgen deprivation therapy (ADT) comes with the risk of side effects, and the effects increase as the therapy is given. Physicians at Fox Chase Cancer Center have determined that local cryosurgery is a viable option to delay or avoid ADT for many of these men.

May 19, 2018

Understanding the Shortcomings of Cystoscopy in Muscle Invasive Bladder Cancer

PHILADELPHIA (May 19, 2018) – Researchers at Fox Chase Cancer Center are seeking to solve a diagnostic dilemma inherent in current treatment recommendations for bladder cancer. This trial marks the first time the true negative predictive value of a normal cystoscopic evaluation  is being identified, allowing researchers to establish how often bladder cancer hides under the mucosa and evades endoscopic diagnosis. 

Pages

Connect with Fox Chase